Cargando…
Neutrophil Elastase Inhibitors: A potential prophylactic treatment option for SARS-CoV-2-induced respiratory complications?
Autores principales: | Mohamed, Mahmoud M. A., El-Shimy, Ismail Amr, Hadi, Muhammad Abdul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276973/ https://www.ncbi.nlm.nih.gov/pubmed/32513225 http://dx.doi.org/10.1186/s13054-020-03023-0 |
Ejemplares similares
-
Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
por: El‐Shimy, Ismail A., et al.
Publicado: (2020) -
Flavonoids as inhibitors of human neutrophil elastase
por: Jakimiuk, Katarzyna, et al.
Publicado: (2021) -
Elastase inhibitor. Characterization of the human elastase inhibitor molecule associated with monocytes, macrophages, and neutrophils
Publicado: (1989) -
Neutrophil Elastase Inhibitors and Chronic Kidney Disease
por: Bronze-da-Rocha, Elsa, et al.
Publicado: (2018) -
Diazaborines as New Inhibitors of Human Neutrophil
Elastase
por: António, João P. M., et al.
Publicado: (2018)